Three-day Clinical Review: Your comprehensive clinical update.
SAVE UP TO 10% WHEN YOU REGISTER!
Register

Three-day Clinical Review

If you are looking for a comprehensive clinical review and don’t want to spend too much time away from the office, attend the Three-Day Clinical Review. The Three-Day Clinical Review includes the GI Pathophysiology Course and What’s New in GI Pharmacology Course, plus the popular Postgraduate Course. Leading experts in the subspecialties will delve deeper into topics of interest to you and address the common and not-so-common GI disorders you encounter in practice.


Friday, October 13, 2017 (Day 1- Morning)
GI Pathophysiology Course

Gain a better understanding of gastrointestinal disease processes and their impact on clinical presentation of patients when you attend the GI Pathophysiology Course. Experts will review the underlying causes and clinical implication of commonly encountered diseases seen in practice. Presentations will focus on:

  • The role of the enteric microbiome and metabolome and potential use of probiotics in various GI disorders, including C. difficile infection
  • Concept to application of novel immunologic approaches for IBD Addressing the when, why and how for the use of molecular and genetic testing in the evaluation and management of colon polyps and cancer
  • Identifying the mechanisms behind novel diagnostic strategies and pharmacologic approaches for patients with celiac disease
  • The rationale and practical approach for using PPIs and elimination diet therapies in managing eosinophilic esophagitis
  • Understanding the pearls and pitfalls in the use of motility, impedance, and pH testing in assessing patients with refractory reflux
  • Using physiologic basis of constipation to inform therapeutic decisions for patients with refractory constipation.

Friday, October 13, 2017 (Day 1 – Afternoon)
What’s New in GI Pharmacology Course

Attend What’s New in GI Pharmacology Course for an intensive review of key GI pharmacology, including comparisons and contrasts between conventional and emerging pharmacological treatment options. This three-hour course will consist of lectures and Q & A sessions on such topics as:

  • Reviewing the appropriate tests, vaccinations, referrals, and medications for patients with IBD on their first visit
  • Use and management of new anticoagulants and reversal agents in patients undergoing endoscopy or experiencing GI bleeding
  • Questions and concerns of long-term use of PPIs based on evidence found in new studies
  • New direct-acting antagonists used to treat chronic hepatitis C
  • Assessing pharmacological treatment options for functional GI disorders
  • Issues and interventions currently available for management of fatty liver disease, including available pharmacologic approaches
  • Addressing safe pharmacological therapies for treatment of GI disorders in the pregnant patient
  • Current options for the prevention and treatment of acute and chronic pancreatitis.

Saturday, October 14 – Sunday, October 15, 2017 (Days 2 and 3 – All Day)
Postgraduate Course

With the need to remain abreast of the many new and emerging advancements in the field of gastroenterology and the volume of patients continuing to increase as the population ages, the clinical gastroenterologist is more challenged than ever to deliver the best patient care in each situation they encounter. Research in a multitude of gastroenterology and hepatology areas progresses at a rapid pace. Advances in technology, diagnostic modalities, and therapeutic options have had a positive impact on the management of many GI diseases. Scientific education, based on critical foundational knowledge and clinical skills, the communication of practical methods for treatment, and the ability to integrate the newest tools in diagnosis with the latest therapeutic/treatment options, are key necessities for the GI clinician to deliver top-quality patient care.

Saturday session topics
  • Functional dyspepsia
  • IBS—pharmacologic and non-pharmacologic therapies
  • Celiac disease
  • Anti-TNFs
  • Detection of dysplasia in IBD surveillance
  • Nonpharmacological options in IBD treatment
  • PPI refractory symptoms
  • Barrett’s esophagus
  • Eosinophilic esophagitis
  • Extra-esophageal GERD
  • Diverticular disease
  • Microscopic colitis
  • Recurrent C. difficile
  • Colorectal cancer screening
  • Autoimmune liver disorders
  • Hepatocellular carcinoma
  • Alcoholic hepatitis
  • PLUS 12 optional learning luncheons
Sunday session topics
  • Quality measures in colonoscopy
  • Cystic lesions of the pancreas
  • Acute pancreatitis
  • Nutrition and pain in chronic pancreatitis
  • Biliary strictures
  • Autoimmune pancreatitis
  • Anti-thrombotic agents
  • Variceal bleeding
  • Non-variceal
  • Upper GI bleeding
  • EMR and ESD
  • Colon cancer and its heredity causes
  • The role of EUS in diagnosis and therapy for pancreatic cancer
  • Endoscopic treatment for and surveillance of gastric cancers
  • Hepatitis C and its global prevalence and incidence
  • Therapy goals in treatment of hepatitis B
  • Benefits and risks for bariatric endoscopy
  • Pre- and post-bariatric medical management
  • Managing complications related to bariatric surgeries
  • PLUS 12 optional learning luncheons